HIGHLIGHTS
- who: Shihui Lai from the Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China have published the Article: N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer, in the Journal: (JOURNAL)
- what: The authors used clinical samples, cytology, animal experiments, and high-throughput sequencing to further explore the effects of AS of CELF2 regulatory_genes on the biological behavior of PC cells, aiming to provide new ideas for the treatment of PC.
- how: This result is consistent with the results of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.